Dong Shin, M.D.
Professor of Hematology and Oncology
Director, Clinical & Translational Cancer Prevention Program
Internal Medicine (Board certified since 1985)
Medical Oncology (Board certified since 1989)
head & neck cancer
lung cancer
mesothelioma
thymoma
Winship Cancer Institute, The Emory Clinic 'C'
1365 Clifton Road, NE Atlanta, GA 30322
(404) 778-1900
Emory University Hospital
Emory University Hospital Midtown
Grady Memorial Hospital
Korean
American Association of Cancer Research
American College of Physicians
American Head and Neck Society
American Society of Clinical Oncology
Combined interferon-á, 13-cis-retinoic acid and á-tocopherol in locally advanced head and neck squamous cell carcinoma: Novel Bioadjuvant Phase II trial. Journal of Clinical Oncology,19:3010-1017, 2001.
P53 protein accumulation and genomic instability in head and neck tumorigenesis.. Cancer Epidermiol Biomarkers and Prevention,10:603-609, 2001.
Phase II Study of Induction Chemotherapy with Paclitaxel, Ifosfamid, and Carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer,95:340-353, 2002.
Phase II and biologic study of interferon-á, 13-cis-retinoic acid, and cisplatin in advanced squamous skin cancer.. Journal of Clinical Oncology,20:364-370, 2002.
Targeting epidermal growth factor receptor: A novel therapeutics in the management of cancer. Exp Reve Anticancer Therapy,3:367-380, 2003.
Medical School
Yonsei University, College of Medicine, Seoul, South Korea 1975
Internship
Yonsei University Hospital, Seoul, South Korea 1979
Residency
Cook County Hospital, Chicago, IL 1985
Fellowship
The University of Texas M.D. Anderson Cancer Center, Houston, TX 1986
